Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine
about
Keratinocyte expression of calcitonin gene-related peptide β: implications for neuropathic and inflammatory pain mechanismsA Potential Preclinical Migraine Model: CGRP-Sensitized Mice.Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats.Epoxyeicosatrienoic acids are endogenous regulators of vasoactive neuropeptide release from trigeminal ganglion neuronsThe Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult SubjectsNeurological mechanisms of migraine: potential of the gap-junction modulator tonabersat in prevention of migraine.Therapeutic antibodies against CGRP or its receptorEpigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia.Tonabersat, a novel gap-junction modulator for the prevention of migraine.Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor AntagonistAn exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.[(11)C]MK-4232: The First Positron Emission Tomography Tracer for the Calcitonin Gene-Related Peptide ReceptorCalcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus.Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons.Sumatriptan inhibition of N-type calcium channel mediated signaling in dural CGRP terminal fibres.Bio-Oss® modified by calcitonin gene-related peptide promotes osteogenesis in vitro.Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor antagonist, in adults.
P2860
Q24616045-7F23FDA4-9664-41E8-B5C8-4B735ED59821Q30482553-3A1DF113-885C-4700-9FCD-3B8A3A5AD855Q33692151-B6FF908D-8334-4A1A-9706-86C7A759F0EBQ34376228-2D062DD1-A22E-4FC9-8315-CF62A2546063Q34462428-991E1F71-EEE0-4FE4-88BC-1C5C27636889Q35124838-A553F51C-307A-4530-B4FA-AC268B90B1DAQ35684794-75CE7FCF-20A5-47E9-A82E-86C4FB42A3B8Q36060346-7EAE1EAD-E95E-45BF-AE3C-956BDEF1A14EQ37590396-F610ED49-FB60-4C13-AB05-6953C39725FEQ37686124-F20B612A-70D1-4D9F-AF3D-DEF3F07BA71CQ39155929-661DC618-7402-4701-B637-B0BE2604C6FAQ39218587-BCF8CB41-CCAB-4B24-B1E2-AD6E94629D3CQ39299115-8B75C3AD-8A84-4940-A541-4FAB036710A8Q39769257-05E26B06-B12D-4C82-9302-152089B0C379Q39948717-63063574-D718-40D3-9C50-D16A17486D85Q41840495-B8F66932-8DE6-4877-ADD6-47AFC06630A1Q42073244-9090D99E-AD1E-48DF-8822-4E1D052BD50BQ42659150-89466ABF-2126-4CC6-B1B9-95DB8FD25F23Q43155089-0B6708E3-16BC-40DB-A25B-34375553D74D
P2860
Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of calcitonin gene- ...... strategy for treating migraine
@en
Inhibition of calcitonin gene- ...... trategy for treating migraine.
@nl
type
label
Inhibition of calcitonin gene- ...... strategy for treating migraine
@en
Inhibition of calcitonin gene- ...... trategy for treating migraine.
@nl
prefLabel
Inhibition of calcitonin gene- ...... strategy for treating migraine
@en
Inhibition of calcitonin gene- ...... trategy for treating migraine.
@nl
P2860
P1433
P1476
Inhibition of calcitonin gene- ...... strategy for treating migraine
@en
P2093
Paul L Durham
P2860
P304
P356
10.1111/J.1526-4610.2008.01215.X
P577
2008-09-01T00:00:00Z